2型糖尿病患者皮下脂肪面积与空腹C肽水平的相关性研究(5)
[15] Wahren J. C-peptide and the pathophysiology of microvascular complications of diabetes [J]. J Intern Med，2017， 281(1)：3-6.
[16] Pujia A，Gazzaruso C，Montalcini T. An update on the potential role of C-peptide in diabetes and osteoporosis [J]. Endocrine，2017，58(3)：408-412.
[17] Pinger CW，Entwistle KE，Bell TM，et al. C-Peptide replacement therapy in type 1 diabetes： are we in the trough of disillusionment？ [J]. Mol Biosyst，2017，13(8)：1432-1437.
[18] Wahren J，Larsson C. C-peptide：new findings and therapeutic possibilities [J]. Diabetes Res Clin Pract，2015， 107(3)：309-319.
[19] He G，Pedersen SB，Bruun JM，et al. Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects [J]. Horm Metab Res，2003，35(3)：178-182.
[20] Li H，Wu G，Fang Q，et al. Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat [J]. Nat Commun，2018，9(1)：272.
[21] Cnop M，Landchild MJ，Vidal J，et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations：distinct metabolic effects of two fat compartments [J]. Diabetes，2002，51(4)：1005-1015.
(收稿日期：2020-03-05 本文編辑：顾家毓), 百拇医药(刘思默 柯静 安雅欣 赵冬)
[16] Pujia A，Gazzaruso C，Montalcini T. An update on the potential role of C-peptide in diabetes and osteoporosis [J]. Endocrine，2017，58(3)：408-412.
[17] Pinger CW，Entwistle KE，Bell TM，et al. C-Peptide replacement therapy in type 1 diabetes： are we in the trough of disillusionment？ [J]. Mol Biosyst，2017，13(8)：1432-1437.
[18] Wahren J，Larsson C. C-peptide：new findings and therapeutic possibilities [J]. Diabetes Res Clin Pract，2015， 107(3)：309-319.
[19] He G，Pedersen SB，Bruun JM，et al. Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects [J]. Horm Metab Res，2003，35(3)：178-182.
[20] Li H，Wu G，Fang Q，et al. Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat [J]. Nat Commun，2018，9(1)：272.
[21] Cnop M，Landchild MJ，Vidal J，et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations：distinct metabolic effects of two fat compartments [J]. Diabetes，2002，51(4)：1005-1015.
(收稿日期：2020-03-05 本文編辑：顾家毓), 百拇医药(刘思默 柯静 安雅欣 赵冬)